Oncomine database analysis revealed that BASP1 mRNA was increased in most types of cancers, including HNSCC, breast cancer, kidney cancer, pancreatic cancer, and lung cancer (Figure 1A). This evidence concerns the gene BASP1 and kidney cancer.